Zydus receives final approval from USFDA for Lubiprostone Capsules, 8 mcg and 24 mcg
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
hubergroup’s two newly added medical vans are dedicated to dental and eye care
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
Integration of modern and traditional medicine to facilitate the illness to wellness journey
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
The audit is a pre-approval inspection for three products filed from the facility
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
Subscribe To Our Newsletter & Stay Updated